Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study
出版年份 2022 全文链接
标题
Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study
作者
关键词
-
出版物
Journal of Asthma and Allergy
Volume Volume 15, Issue -, Pages 63-78
出版商
Informa UK Limited
发表日期
2022-01-13
DOI
10.2147/jaa.s328653
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effect of Anti-IL5, Anti-IL5R, Anti-IL13 Therapy on Asthma Exacerbations: A Network Meta-analysis
- (2020) Richard P. Ramonell et al. LUNG
- Therapeutic Potential of Dupilumab in the Treatment of Chronic Rhinosinusitis with Nasal Polyps: Evidence to Date
- (2020) Jean Kim et al. Therapeutics and Clinical Risk Management
- Antibodies targeting the interleukin-5 signaling pathway used as add-on therapy for patients with severe eosinophilic asthma: a review of the mechanism of action, efficacy, and safety of the subcutaneously administered agents, mepolizumab and benralizumab
- (2020) Georgios Hillas et al. Expert Review of Respiratory Medicine
- Biologic and maintenance systemic corticosteroid therapy among US subspecialist-treated patients with severe asthma
- (2020) Wendy C. Moore et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Clinical use of biologics for asthma treatment by allergy specialists
- (2020) Merin Kuruvilla et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- International severe asthma registry (ISAR): protocol for a global registry
- (2020) J. Mark FitzGerald et al. BMC Medical Research Methodology
- Significant improvement in lung function and asthma control after benralizumab treatment for severe refractory eosinophilic asthma
- (2020) Francesco Menzella et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Characterization of severe asthma worldwide: data from the International Severe Asthma Registry (ISAR)
- (2019) Wang Eileen et al. CHEST
- Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation
- (2019) Audrey Le Floc’h et al. ALLERGY
- International Severe Asthma Registry
- (2019) G. Walter Canonica et al. CHEST
- An expert consensus framework for asthma remission as a treatment goal
- (2019) Andrew Menzies-Gow et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
- (2018) Mario Castro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies
- (2018) J Mark FitzGerald et al. Lancet Respiratory Medicine
- Consequences of long-term OCS therapy and its side effects in severe asthma in adults – A focused review of the impact data in the literature
- (2018) Timm Volmer et al. EUROPEAN RESPIRATORY JOURNAL
- Development of the International Severe Asthma Registry (ISAR): a modified Delphi study
- (2018) Lakmini Bulathsinhala et al. Journal of Allergy and Clinical Immunology-In Practice
- Role of Biologics in Asthma
- (2018) Mary Clare McGregor et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Biologic treatment eligibility for real-world patients with severe asthma: The IDEAL study
- (2017) Frank C. Albers et al. JOURNAL OF ASTHMA
- Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
- (2015) Mario Castro et al. Lancet Respiratory Medicine
- Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
- (2014) Hector G. Ortega et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started